doi:10.1002/jor.21107 Evidence-Base Disclosure The published evidence base for BPC-157 consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments
Within even some of the reviews that have been written, people get things confused as to whether or not a given peptide that one would use as a therapeutic falls into one or the other category
Initial post-treatment discomfort is generally mild, similar to the feeling after a hard work out, and is easily controlled with oral medication, usually Tylenol, but a narcotic can be used if needed
Contact PlexusDx for a replacement
Green et al 26 Severe clinical abnormalities should be treated intensively with B 12 , cyanoB 12 or hydroxyB 12 : HydroxyB 12 is commonly used in Europe, often at intervals of 23 months, as it seems to have better retention than cyanoB 12